The Effectiveness of Group Schema Therapy in the Treatment of Borderline Symptoms in Adolescents
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-22
SponsorTurku University Hospital
About this trial
The goal of this randomized and controlled trial is to assess the effectiveness of group schema therapy in the treatment of adolescents with borderline symptoms. The intervention utilizes self-recorded video material as an experiential method. The intervention comprises 30 group sessions and 8 individual sessions. Additionally, there are group sessions for the participants' parents. Participants in the control group receive treatment as usual.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
The participant fulfills at least three diagnostic criteria for borderline personality disorder as assessed by means of the SCID-II structured clinical interview
The participant and the participant's parent(s) are able to commit to the research protocol for the entire duration of the study
The participant is able to participate in a research intervention in Finnish and fill out the study questionnaires in Finnish
Disqualifiers
The participant currently has psychotic symptoms or a serious risk of suicide
The participant has been diagnosed with an intellectual disability or an autism spectrum disorder
The main clinical diagnosis of the participant is a substance abuse disorder or substance use would endanger commitment to the research intervention
The participant has another illness or symptom that endangers the participant's ability to complete the study
Trial design
Design model
Parallel
Treatments tested in this trial
Group schema therapy
BehavioralGroup schema therapy based on the model by Farrell and Shaw, which is complemented with separate group sessions for the participants' parents
Treatment as Usual (TAU)
BehavioralTAU typically comprises visits at the outpatient clinic with variable frequency and content
Treatment groups
64 Participants
are divided into 2 treatment groupsGroup A: Group schema therapyExperimental treatment 1 intervention
Group B: ControlActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Borderline Symptom List - Short version
Time frame
From enrollment to the end of treatment at 12 monthsSecondary outcomes
1
Young Schema Questionnaire Short Form 2 -Extended
Time frame
From enrollment to the end of treatment at 12 months2
Schema Mode Inventory
Time frame
From enrollment to the end of treatment at 12 months3
Patient Health Questionnaire-9
Time frame
From enrollment to the end of treatment at 12 months4
Child and Adolescent Trauma Screen
Time frame
From enrollment to the end of treatment at 12 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Turku University Hospital
Lead sponsor
University of Turku
Collaborator
Source ClinicalTrials.gov